Hyaluronic acid dermal fillers: Can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Patient Preference and Adherence

Volumn 5, Issue , 2011, Pages 133-139

  Smith, Lynnelle ^a   Cockerham, Kimberly ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Collagen; Drug toxicity; Herpes simplex; Hyaluronic acid; Hypersensitivity; Lidocaine

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; BOTULINUM TOXIN; COLLAGEN; COLLAGEN IMPLANT; EMLA; HYALURONIC ACID; HYALURONIDASE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMETHACRYLIC ACID; STEROID; TACROLIMUS;

ASPIRATION; CLINICAL EFFECTIVENESS; DRUG HYPERSENSITIVITY; ESTHETIC SURGERY; HERPES SIMPLEX; HUMAN; HYDROGEL; HYPERSENSITIVITY; INJECTION SITE ABSCESS; INJECTION SITE DISCOLORATION; INJECTION SITE ERYTHEMA; INJECTION SITE NECROSIS; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; ISCHEMIA; LOW DRUG DOSE; MARKETING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SAFETY; SKIN BRUISING; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

EID: 84856151728     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S11251     Document Type: Review

References (26)

1. Levy PM, de Boulle K, Raspaldo H. A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther. 2009;11(3):169-173.
2. Beasley KL, Weiss MA, Weiss RA. Soft tissue augmentation using a two-way connector to supplement hyaluronic acid filler with 1% lidocaine hydrochloric acid with epinephrine 1:100,000: our experience and observations. Dermatol Surg. 2010;36(4):524-526.
3. Levy PM, de Boulle K, Raspaldo H. Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg. 2009;35 Suppl 1:332-336; discussion 337.
4. Monheit GD, Campbell RM, Neugent H, et al. Reduced pain with use of proprietary hyaluronic acid with lidocaine for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg. 2010;36(1):94-101.
5. Research B. Cosmetic surgery markets: products and services. Last updated 2008. Available from: http://www.reportlinker.com/p0132720/Cosmetic-Surgery-Markets-Products-and-Services.html. Accessed October 8, 2010.
6. McCracken MS, Khan JA, Wulc AE, et al. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg. 2006;22(3):188-191.
7. Rohrich RJ, Herbig KS. Minimizing pain, maximizing comfort: a new technique for facial filler injections. Plast Reconstr Surg. 2009;124(4): 1328-1329.
8. Weinkle SH, Bank DE, Boyd CM, Gold MH, Thomas JA, Murphy DK. A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine. J Cosmet Dermatol. 2009;8(3):205-210.
9. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153-159.
10. Custis T, Beynet D, Carranza D, Greco J, Lask GP, Kim J. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. Dermatol Surg. 2010;36 Suppl 3:1852-1858.
11. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg. 2003;29(8):802-809.
12. Baumann L. Dermal fillers. J Cosmet Dermatol. 2004;3(4):249-250.
13. van Dyke S, Hays GP, Caglia AE, Caglia M. Severe acute local reactions to a hyaluronic acid-derived dermal filler. J Clin Aesthet Dermatol. 2010;3(5):32-35.
14. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol. 2008;22(2):150-161.
15. Pinsky MA, Thomas JA, Murphy DK, Walker PS; Juvéderm vs Zyplast Nasolabial Fold Study Group. Juvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthet Surg J. 2008;28(1):17-23.
16. Librowski T, Pytka K, Szaleniec M. Antihistaminic activity of carane derivatives in isolated guinea pig ileum. Pharmacol Rep. 2009;61(6): 1211-1215.
17. Lupo MP, Swetman G, Waller W. The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial. J Drugs Dermatol. 2010;9(9):1097-1100.
18. Wahl G. European evaluation of a new hyaluronic acid filler incorporating lidocaine. J Cosmet Dermatol. 2008;7(4):298-303.
19. Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol. 2009;8(3): 162-168.
20. Bachmann F, Erdmann R, Hartmann V, Wiest L, Rzany B. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg. 2009;35 Suppl 2:1629-1634.
21. Narins RS, Jewell M, Rubin M, Cohen JL, Strobos J. Clinical conference: management of rare events following dermal fillers - focal necrosis and angry red bumps. Dermatol Surg. 2006;32(3):426-434.
22. Kohase H, Umino M. Allergic reaction to epinephrine preparation in 2% lidocaine: two case reports. Anesth Prog. 2004;51(4):134-137.
23. Mackley CL, Marks JG Jr, Anderson BE. Delayed-type hypersensitivity to lidocaine. Arch Dermatol. 2003;139(3):343-346.
24. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther. 2005;7(3-4):171-176.
25. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34 Suppl 1:S92-S99
26. Cockerham K, Hsu VJ. Collagen-based dermal fillers: past, present, future. Facial Plast Surg. 2009;25(2):106-113.